Lovastatin Tablet
Product Images NDC 71335-0045

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 71335-0045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl713350045)

Label Image (Lbl713350045)
Lovastatin is a drug used to lower cholesterol levels in the body. The description provides information about the medication's dosage - 40mg. The appearance of the tablet is white, round with engraved letters of CTI;143. The tablets should be stored at room temperature (20°-25°C) and should be kept away from children. The description also includes details about the manufacturer's name, Buyant Ranch Prcpach Bunbank and Carlsbad Technology Inc. Additionally, the presence of a unique identification code, NDC 7133500451 01784301523487, and an expiry date, "EXP MM/YY," is noted. However, it is unclear what "Dachaged" means, and it is possible that it is not relevant to the medication described.*
FDA Label Image

Structural Formula (Lov00 0004 01)

Structural Formula (Lov00 0004 01)
FDA Label Image

Table I (Lov00 0004 02)

Table I (Lov00 0004 02)
Not available. The text provided seems to be incomplete and does not provide any useful information.*
FDA Label Image

Figure 1 (Lov00 0004 03)

Figure 1 (Lov00 0004 03)
This is a graph labeled "Figure 1" that displays the proportion of participants without acute major coronary events (primary endpoint) over the course of 4 years of follow-up. No further information is available.*
FDA Label Image

Table Vii (Lov00 0005 04)

Table Vii (Lov00 0005 04)
This is a drug interaction table that lists medications and their associated increased risk of myopathy or rhabdomyolysis. The medications are categorized into different groups, such as strong CYP3A4 inhibitors, HIV protease inhibitors, and gemfibrozil. The table includes prescribing recommendations for each drug such as avoiding grapefruit juice, not exceeding a certain dosage of lovastatin, and contraindications with other medications.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.